Bioray Biotech Co., Ltd (7561.TWO)

TWD 19.35

(-1.02%)

EBITDA Summary of Bioray Biotech Co., Ltd

  • Bioray Biotech Co., Ltd's latest annual EBITDA in 2023 was 12.13 Million TWD , down -50.23% from previous year.
  • Bioray Biotech Co., Ltd's latest quarterly EBITDA in 2024 Q2 was -3.68 Million TWD , down -122.05% from previous quarter.
  • Bioray Biotech Co., Ltd reported an annual EBITDA of 24.27 Million TWD in 2022, up 75.68% from previous year.
  • Bioray Biotech Co., Ltd reported an annual EBITDA of 13.86 Million TWD in 2021, down -9.43% from previous year.
  • Bioray Biotech Co., Ltd reported a quarterly EBITDA of -3.68 Million TWD for 2024 Q2, down -122.05% from previous quarter.
  • Bioray Biotech Co., Ltd reported a quarterly EBITDA of -814.5 Thousand TWD for 2023 Q1, down -124.36% from previous quarter.

Annual EBITDA Chart of Bioray Biotech Co., Ltd (2023 - 2019)

Historical Annual EBITDA of Bioray Biotech Co., Ltd (2023 - 2019)

Year EBITDA EBITDA Growth
2023 12.13 Million TWD -50.23%
2022 24.27 Million TWD 75.68%
2021 13.86 Million TWD -9.43%
2020 14.99 Million TWD 0.39%
2019 15.24 Million TWD 0.0%

Peer EBITDA Comparison of Bioray Biotech Co., Ltd

Name EBITDA EBITDA Difference
Allied Biotech Corporation 204.79 Million TWD 94.074%
GeneFerm Biotechnology Co., Ltd. 231.09 Million TWD 94.749%
Easywell Biomedicals, Inc. -85.5 Million TWD 114.193%
TTY Biopharm Company Limited 1.52 Billion TWD 99.204%
Synmosa Biopharma Corporation 1 Billion TWD 98.797%
Orient EuroPharma Co., Ltd. 582.93 Million TWD 97.918%
Center Laboratories, Inc. -175.17 Million TWD 106.928%
Tien Liang BioTech Co., Ltd. 31.04 Million TWD 60.915%
Orient Pharma Co., Ltd. 172.39 Million TWD 92.961%
InnoPharmax Inc. -62.12 Million TWD 119.535%
Johnson Chemical Pharmaceutical Works Co., Ltd. 126.67 Million TWD 90.421%
Excelsior Biopharma Inc. -29.36 Million TWD 141.319%
DV Biomed Co., Ltd. 407.64 Million TWD 97.023%
Foresee Pharmaceuticals Co., Ltd. -912.16 Million TWD 101.33%
Handa Pharmaceuticals, Inc. 802.78 Million TWD 98.488%
UniPharma Co., Ltd. -16.25 Million TWD 174.659%
Anxo Pharmaceutical Co., Ltd. 131.31 Million TWD 90.759%
Alar Pharmaceuticals Inc. 394.52 Million TWD 96.924%
Winston Medical Supply Co., Ltd. 228.32 Million TWD 94.685%
Mercury Biopharmaceutical Corporation -39.03 Million TWD 131.088%
TSH Biopharm Corporation Limited 99.35 Million TWD 87.786%